Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Ken Crooks who wrote (433)	12/23/1997 7:24:00 PM
From: Brander	Read Replies (1) \| Respond to of 834

Wexler does not know much substantial about TXB. He is making slanderous accusations with no facts to back them up. He has not answered any of my questions, or provided any evidence to his slanderous claim that Novastan will be rejected by the FDA. He has also been dead wrong in saying that the FDA had nothing to do with TXB, that Rapid Review has nothing to do with the liklihood that a drug will be reviewed, and that no reputable journal supports TXB. "Seems that you may be pushing slander laws on this. " I very strongly agree with this, since he is making potentially damaging accusations with no evidence to back up his claims. Brad